1600. Long-Acting Antiretroviral Injectable: Who Would Benefit?

BACKGROUND: People with HIV (PWH) face many challenges in obtaining HIV care. Long-acting (LA)-injectable antiretroviral therapies (ART) can address some of these barriers. This project aimed to determine the percentage of patients who could receive the LA-injectable ART cabotegravir/rilpivirine (CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Pogorzelski, Karolina, Dandachi, Dima, Hitchcock, Nicole M, Fabricius, Michela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677661/
http://dx.doi.org/10.1093/ofid/ofad500.1435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677661/
http://dx.doi.org/10.1093/ofid/ofad500.1435

Ejemplares similares